Qualtech Consulting Corporation is honored to have assisted Sunmax Biotech to open up the Chinese medical beauty market for its products. Sunmax Biotech had targeted the Chinese market starting from its first generation of products. Through efficient teamwork and an outstanding cooperation, Sunmax and Qualtech obtained the first approval for Sunmax’s collagen facial implant product in China in the year 2014. Earlier this year, the third generation product, Sunmax FACIALGAIN Collagen Implant with Lidocaine, has also received China NMPA approval in April. Through the close collaboration between manufacturer and consulting company, the team of Sunmax and Qualtech were able to greatly enhance Sunmax’s market presence in China.